ClinicalTrials.gov
public full text
Public Domain
Effect of Montelukast on the Expression and Variation of TGF-β for Children With Mild Persistent Asthma
The Objective of our research is to observe the effect of cysteinyl leukotriene receptor antagonist on the expression and variation of TGF-β1 levels and mRNA expression in children with mild persistent asthma in their plasma and T lymphocyte, to discuss the role of TGF-β1 in the pathogenesis of bronchial asthma in children and to evaluate the function of regulation of leukotriene receptor antagonist on asthma in children.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Effect of Addition Oral Montelukast to Standard Treatment in Acute Asthma in Hospitalized Preschool Children#1057953
- Preoperative Use of Montelukast Sodium#900362
- Montelukast in Modulating Exacerbations of Asthma in Children#1102540
- Fractional Concentration of Exhaled NO(FeNO) to Direct The Treatment of Sub-acute Cough#994041
- The Leukotriene Modifier Or Corticosteroid or Corticosteroid-Salmeterol Trial#812713
Record · ID 812276
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive